Physical and technical quality assurance in the CHARTWEL-Bronchus trial

Strahlentherapie und Onkologie

Volumn 179, Issue 3, 2003, Pages 152-157

  Lehmann, Dietmar ^a   Leetz, Hans Karl ^c   Hodapp, Norbert ^b   Voigtmann, Lutz ^a   Herrmann, Thomas ^a   Baumann, Michael ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Universität Dresden ^*

Author keywords

CHARTWEL Bronchus trial; External audits; Physical quality assurance; Radiation therapy; Randomized clinical trial

Indexed keywords

ARTICLE; CALIBRATION; CLINICAL TRIAL; DOSE CALCULATION; IONIZATION CHAMBER; LUNG; PHANTOM; POLICY; QUALITY CONTROL; QUESTIONNAIRE; RADIATION DOSE; SPINAL CORD; TREATMENT PLANNING;

HUMANS; LUNG; MULTICENTER STUDIES; PHANTOMS, IMAGING; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; QUESTIONNAIRES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RANDOMIZED CONTROLLED TRIALS; SPINAL CORD; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037336621     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-003-1008-1     Document Type: Article

References (15)

1. Aird EGA, Williams C, Mott GTM, Dische S, Saunders MI. Quality assurance in the CHART clinical trial. Radiother Oncol 1995;36:235-45.
2. Baumann M, Flentje M, Drings P. Entwicklungen in der primären Strahlentherapie und Radiochemotherapie beim nichtkleinzelligen Bronchialkarzinom. Onkologe 2002;8:448-61.
3. Baumann M, Herrmann T, Matthiessen W, Koch R, Strelocke K, Paul U. CHARTWEL-Bronchus (ARO 97-1): a randomized multicentre trial to compare conventional fractionated radiotherapy with CHARTWEL radiotherapy in inoperable non-small-cell bronchial carcinoma. Strahlenther Onkol 1997;173:663-7.
4. Bentzen SM, Saunders SI, Dische S. From CHART to CHARTWEL in non-small cell lung cancer: clinical radiobiological modelling of the expected change in outcome. Clin Oncol 2003:in press.
5. Dische S, Saunders MI. Continuous, hyperfractionated, accelerated radiotherapy (CHART). Br J Cancer 1989;59:325-6.
6. Ferreira IH, Richter J, Dutreix A, Bridier A, Chavaudra J, Svensson H. The ESTRO-EQUAL quality assurance network for photon and electron radiotherapy beams in Germany. Strahlenther Onkol 2001;177:383-93.
7. Kiricuta IC. Selection and delineation of lymph node target volume for lung cancer conformal radiotherapy. Proposal for standardizing terminology based on surgical experience. Strahlenther Onkol 2001;177:410-23.
8. Lieven H von, Burkhardt E. Postoperative radiotherapy of NSCLC - outcome after 3-D treatment planning. Strahlenther Onkol 2001;177:302-6.
9. Saunders M, Dische S, Barrett A, Harvey A, Gibson D, Parmar M. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. Lancet 1997;350:161-5.
10. Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Parmar M. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: mature data from the randomised multicentre trial. Radiother Oncol 1999;52:137-48.
11. Saunders M, Dische S, Parmar MKB, Harvey A, Gibson D. Randomised multicentre of CHART vs. conventional radiotherapy in head and neck and nonsmall-cell lung cancer: an interim report. Br J Cancer 1996;73:1455-62.
12. Saunders M, Rojas A, Lyn BE, Pigott K, Powell M, Goodchild K, Hoskin PJ, Philips M, Verma N. Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in nonsmall-cell lung cancer. Br J Cancer 1998;78:1323-8.
13. Schraube P, Spahn U, Oetzel D, Wannenmacher M. Effekt der 3D-gegenüber der 2D-Bestrahlungsplanung innerhalb eines konventionellen Therapieschemas fortgeschrittener Bronchialkarzinome. Strahlenther Onkol 2000;176:32-9.
14. Slanina J, Laubenberger J. CT-based study on potential mediastinals lymph node spread of patients with lung cancer. Contribution to 3-D treatment planning for adjuvant radiotherapy of the mediastinum. Strahlenther Onkol 2002;178:199-208.
15. Studienbeschreibung CHARTWEL-Bronchus der Arbeitsgemeinschaft Radioonkologie (ARO) der Deutschen Krebsgesellschaft (Protokoll 97-1) vom 1.1.1997.